Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.
about
Leukotriene B4 and asthma.Effect of pranlukast, a leukotriene receptor antagonist, in patients with severe asthma refractory to corticosteroids.Novel enzymatic abnormalities in AML and CML in blast crisis: elevated leucocyte leukotriene C4 synthase activity paralleled by deficient leukotriene biosynthesis from endogenous substrate.Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease.
P2860
Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.
@en
type
label
Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.
@en
prefLabel
Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.
@en
P2860
P356
P1433
P1476
Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.
@en
P2093
P2860
P304
P356
10.1136/THX.50.9.1005
P407
P577
1995-09-01T00:00:00Z